SCHEMBL125485

SCHEMBL125485

O=C(O)S(=O)(=O)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17006489 0.95 CA1 (0.33)
Benzene SCHEMBL27378327 0.91 SRC (0.36)
SCHEMBL174851 0.70
Sulfuric Acid SCHEMBL10478991 0.67 CA5A (0.55)
SCHEMBL28680067 0.67
SCHEMBL2046056 0.67
Phosphine SCHEMBL15510502 0.67
SCHEMBL30733162 0.67
Hydrochloric Acid SCHEMBL21646118 0.67
SCHEMBL11033059 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110461869-B Design of therapeutic immunoglobulin G4 for improved bioassay and bioprocessing characteristics 百时美施贵宝公司 2024-02-06 CN claimed
US-7045644-B2 Imidochromium compounds in catalyst systems for olefin polymerization BASELL POLYOLEFINE GMBH (DE) 2006-05-16 US claimed
US-20260146061-A1 SYSTEMS AND METHODS FOR END TO END CONTINUOUS DOWNSTREAM PROCESSING ASTRAZENECA AB (SE) 2026-05-28 US disclosed
US-12630583-B2 Methods of purifying proteins using chromatography BRISTOL-MYERS SQUIBB COMPANY (US) 2026-05-19 US disclosed
CN-122036751-A Novel contrast agents for diagnostic imaging 拜耳公司 2026-05-15 CN disclosed
US-20260109602-A1 METHOD TO MAKE PHOSPHORIC ACID AND AMMONIUM PHOSPHATES FROM PHOSPHATE MINERAL WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2026-04-23 US disclosed
US-12590142-B2 Antibody purification and purity monitoring H. LUNDBECK A/S (DK) 2026-03-31 US disclosed
EP-4655316-A1 METHOD FOR REDUCING PROTEASE ACTIVITY IN A SOLUTION COMPRISING ANTI-D IMMUNOGLOBULIN G CSL Behring AG (CH) 2025-12-03 EP disclosed
EP-4642930-A2 COMPOSITIONS, DEVICES AND METHODS FOR AN IMPROVED RAPID POINT-OF-USE DIAGNOSTIC ASSAY Hypercell Technologies (US) 2025-11-05 EP disclosed
US-12351456-B2 Method to make phosphoric acid and ammonium phosphates from phosphate minerals WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2025-07-08 US disclosed
US-12312394-B2 Methods of producing anti-C5 antibodies ALEXION PHARMACEUTICALS, INC. (US) 2025-05-27 US disclosed
WO-1991009117-A1 PROCESS FOR ISOLATING GALACTOSE OXIDASE THE PROCTER & GAMBLE COMPANY (US) 1991-06-27 WO disclosed
EP-0226313-B1 PARTIALLY CRYSTALLINE POLY(SULFONE ESTER) RESIN ARCO CHEMICAL TECHNOLOGY, INC. (US) 1990-12-27 EP disclosed
EP-0226313-A1 Partially crystalline poly(sulfone ester) resin ARCO CHEMICAL TECHNOLOGY, INC. (US) 1987-06-24 EP disclosed
US-4645820-A MOLDING MATERIAL FROM DIHYDRIC PHENOL, BIS(A,A-DISUBSTITUTED ACETIC ACID) SULFONE, AND 4,4*-BENZOPHENONE DICARBOXYLIC ACID ATLANTIC RICHFIELD COMPANY (US) 1987-02-24 US disclosed
EP-0210763-A1 Moldable polyester-sulfone thermoplastic resin ARCO CHEMICAL TECHNOLOGY, INC. (US) 1987-02-04 EP disclosed
US-4614767-A FROM DIHYDRIC PHENOL AND A BISCA,A-DISUBSTITUTED ACETIC ACID ATLANTIC RICHFIELD COMPANY (US) 1986-09-30 US disclosed
US-4529665-A For curable composition PPG INDUSTRIES, INC. (US) 1985-07-16 US disclosed
EP-0109818-A2 Process for the preparation of penicillin and cephalosporin sulfones ELI LILLY AND COMPANY (US) 1984-05-30 EP disclosed
US-3943040-A Microcracked chromium from a bath using an organic sulfur compound THE HARSHAW CHEMICAL COMPANY (US) 1976-03-09 US disclosed